Accretive Health, Inc. announced that revenue that it had under contract and what that contract of revenue will delivered over the next 12 months, is in the range of $930 million to $960 million. Net revenue is expected to be at the low end of the range of $948 million to $980 million. Adjusted EBITDA is expected to be in the middle of the range of $50 million to $55 million for 2012.

That does include $30 million to $33 million of nonrecurring events that happened during 2012. And adjusted EPS is supposed to be in the range of $0.23 to $0.27 a share.